MENU
ALNY
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Alnylam Pharmaceuticals (ALNY) Ownership - Who owns Alnylam Pharmaceuticals?
Industry: @Biotechnology
Profile
Industry
Biotechnology
Address
675 West Kendall Street
Phone
+1 617 551-8200
Employees
2100
Web
https://www.alnylam.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
31.8B
P/E Ratio
N/A
Total Cash
2.78B
Projected Growth
N/A
Total Debt
1.3B
Revenue
2.09B
Risk (Beta)
0.34
Dividend Yield
N/A
Total Cash/Share
21.56
Total Debt/Equity
N/A
Revenue/Share
16.52 USD as % of share price
Fundamentals
ALNY
Capitalization
31.8B
P/E Ratio
N/A
Risk (Beta)
0.34
Dividend Yield
N/A
Total Cash
2.78B
Total Cash/Share
21.56
Total Debt
1.3B
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
16.52%
Revenue
2.1B
ROE
N/A
Book Value
32.4M
P/B Ratio
1000.00
Cash Flow
N/A
Earnings
-2.62
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
1.29M
Current Ratio
2.75
Current Revenue Per Employee
238532.86
Dividends Per Share - Security
N/A
EBITDA
-85.69M
Float
N/A
Float - Current
N/A
Gross Income Margin
82.85
Revenue To Assets
-8.26
Shares Held By Institutions
69.7B
Shares Outstanding - Current
129M
Total Liabilities
4.17B
Total Volume MTD
N/A
Value
-1
Gain YTD
28.823
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of therapeutics based on RNA interference
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
675 West Kendall Street
Phone
+1 617 551-8200
Employees
2100
Web
https://www.alnylam.com